JACOBS LEVY EQUITY MANAGEMENT, INC
Position in LAB — Standard Biotools Inc.
CIK 884414
FLORHAM PARK, NJ
Position in LAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,339,151
-$544,636 QoQ
Shares Held
1,633,112
+544.1% QoQ
Ownership
0.416%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 143 holders
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in LAB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $498,618,445 across 25 Medical Devices names. LAB ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
2,772,232 | $250,776,106 | |
| 2 | GEHC |
GE HealthCare Technologies Inc.
|
1,862,023 | $119,188,092 | |
| 3 | TNDM |
Tandem Diabetes Care Inc
|
2,006,429 | $30,277,013 | |
| 4 | ATEC |
Alphatec Holdings, Inc.
|
3,352,133 | $28,995,950 | |
| 5 | AXGN |
Axogen, Inc.
|
386,423 | $17,848,878 | |
| 6 | NVCR |
NovoCure Ltd
|
1,164,072 | $17,635,690 | |
| 7 | VREX |
Varex Imaging Corp
|
479,785 | $5,004,157 | |
| 8 | RXST |
RxSight, Inc.
|
998,569 | $4,813,102 |
All Filings in LAB
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,339,151 | 1,633,112 | Shares | Sole | 2026-08-14 | |
| 2020-09-30 | $1,883,787 | 253,538 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,684,833 | 420,158 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $961,161 | 378,410 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||